Do You Need a Pap Smear or Mammogram Before Starting Hormone Therapy?

The short answer

Hormone therapy does not require a pelvic exam or a Pap test to start.

What it does require is that your routine screening is current for your age, and that your history has been reviewed carefully.

Those are two different things, and conflating them is where people get confused.

Cervical cancer screening

Current guidance for most women is a Pap test every three years from 21 to 29, and from 30 to 65 either Pap every three years, HPV testing every five years, or co-testing every five years. The U.S. Preventive Services Task Force updated its recommendations in 2025 to include self-collected HPV testing as an option in some settings.

If you're due, get it done. If you're not, you're not — and being due doesn't have to hold up your treatment plan in every case.

What I do need to know: your last screening date and result, and whether you've had an abnormal result that's still being followed.

Mammography

Standard screening guidance applies. The USPSTF recommends biennial screening mammography beginning at age 40 through 74; other organizations offer annual screening starting at 40. Your personal and family history can move that earlier.

Two things worth saying plainly:

Hormone therapy is not a reason to screen more frequently than recommended.

And estrogen-progestogen therapy can slightly increase breast density on imaging, which occasionally means a callback for additional views. That's worth knowing in advance so it isn't frightening if it happens.

If you're due for a mammogram, I want it scheduled. Not because a normal mammogram makes hormone therapy safe, but because screening should be current regardless.

What actually determines whether you're a candidate

Most of the decision comes from your history, not from a test:

• Personal history of breast cancer or another hormone-sensitive cancer
• History of blood clots — DVT or pulmonary embolism — or a known clotting disorder
• Prior stroke, heart attack, or significant cardiovascular disease
• Active liver disease
• Unexplained vaginal bleeding
• Migraine with aura
• Smoking status
• Blood pressure
• Family history of breast cancer, ovarian cancer, or clotting disorders

Several of those aren't automatic disqualifications. Migraine with aura, for example, generally steers me toward transdermal estradiol rather than oral. A family history of breast cancer changes the conversation and the risk-benefit weighing without ending it.

Bleeding is the hard stop

Unexplained vaginal bleeding — bleeding after menopause, or bleeding that's new, heavy, or irregular in a way we can't account for — is evaluated before hormone therapy starts.

That usually means a pelvic ultrasound, sometimes an endometrial biopsy, and an in-person referral. I'd rather delay a prescription by three weeks than start estrogen on top of something that hasn't been looked at.

What I typically order

For most women starting hormone therapy, that means blood pressure, a metabolic panel, lipids, thyroid function, a CBC, vitamin D, and hormone levels when they'll actually change a decision. Bone density if you have risk factors or early menopause.

Laboratory testing is billed separately from the program fee. If you've had recent labs, send them — I'll review those first rather than repeating work.

The bottom line

You do not need a pelvic exam to be prescribed hormone therapy, and you should not have to sit in a waiting room to have this conversation.

You do need current screening, an honest history, and a clinician who will send you for an in-person evaluation when something needs eyes and hands on it. That's what I do.